Page 1 of Clinical Trials for "Lenalidomide", 444 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients
Last Updated: December 28, 2011
Condition(s): Multiple Myeloma
2
Recruiting
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia Subjects ≥ 65 Years of Age
Last Updated: May 1, 2012
Condition(s): Acute Myeloid Leukemia; Acute Myelogenous Leukemia
3
Recruiting
Use of Thalidomide, Lenalidomide, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients
Last Updated: March 19, 2012
Condition(s): Multiple Myeloma
4
Completed
Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality
Last Updated: April 12, 2011
Condition(s): Myelodysplastic Syndromes
5
Recruiting
Azacitidine and Lenalidomide for Acute Myeloid Leukemia
Last Updated: October 6, 2011
Condition(s): Leukemia, Myeloid, Acute
6
Recruiting
Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma
Last Updated: September 8, 2011
Condition(s): Relapsed Multiple Myeloma
7
Active, not recruiting
Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma
Last Updated: May 18, 2012
Condition(s): Hodgkin Disease
8
Active, not recruiting
A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older
Last Updated: May 10, 2012
Condition(s): Newly Diagnosed Multiple Myeloma
9
Not yet recruiting
Vorinostat Plus Lenalidomide and Dexamethasone or Lenalidomide Plus Dexamethasone in Multiple Myeloma Patients Who Experience Biochemical Relapse During Lenalidomide Maintenance Therapy
Last Updated: December 28, 2011
Condition(s): Multiple Myeloma
10
Recruiting
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
Last Updated: May 4, 2012
Condition(s): Advanced Cancers
11
Recruiting
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Last Updated: April 23, 2012
Condition(s): Multiple Myeloma; Plasma Cell Neoplasm
12
Terminated
A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With Cetuximab in Pre-treated Patients With KRAS Mutant Colorectal Cancer
Last Updated: February 10, 2011
Condition(s): Colorectal Cancer
13
Recruiting
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
Last Updated: April 30, 2012
Condition(s): Multiple Myeloma
14
Terminated
A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Last Updated: August 27, 2009
Condition(s): Diffuse Large B-cell Lymphoma
15
Recruiting
Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L
Last Updated: January 19, 2012
Condition(s): Multiple Myeloma
16
Recruiting
Lenalidomide for Myelodysplastic Syndrome Refractory to Hypomethylating Agents
Last Updated: October 6, 2011
Condition(s): Myelodysplastic Syndromes
17
Recruiting
Comparison of 25mg Versus 5 mg Lenalidomide as Maintenance Therapy in Patients With Multiple Myeloma
Last Updated: June 10, 2010
Condition(s): Multiple Myeloma
18
Recruiting
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Last Updated: September 8, 2010
Condition(s): Chronic Lymphocytic Leukemia; CLL; Untreated; Front-line; First-Line; Initial Therapy
19
Recruiting
Lenalidomide for Lean Body Mass and Muscle Strength in Inflammatory Cancer Cachexia Syndrome
Last Updated: May 19, 2010
Condition(s): Cancer Cachexia Syndrome
20
Completed
A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
Last Updated: September 26, 2011
Condition(s): Relapsed or Refractory Multiple Myeloma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%22Lenalidomide%22

Page 1 of Clinical Trials for "Lenalidomide", 444 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About